Skip to main content
. 2020 Nov 3:1–16. doi: 10.1080/07391102.2020.1841680

Figure 6.

Figure 6.

Analysis of Mpro secondary structure in different systems during 100 ns MD simulation. The secondary structure content of Mpro in (A) unligated Mpro system, (B) Mpro-N3 system, (C) Mpro-lopinavir system, (D) Mpro-amentoflavone system, (E) Mpro-bilobetin system and (F) Mpro-ginkgetin system.